Results 81 to 90 of about 6,225,689 (197)

Clinical significance and heterogeneity of circulating tumor cells and clusters in breast cancer subtypes [PDF]

open access: yesPeerJ
The marked heterogeneity of breast cancer results in substantial variations in clinical characteristics, metastatic patterns, and prognosis across molecular subtypes.
LiangYu Hao, Lixiang Zheng
doaj   +2 more sources

Computational ranking identifies Plexin-B2 in circulating tumor cell clustering with monocytes in breast cancer metastasis

open access: yesNature Communications
Multicellular circulating tumor cell (CTC) clusters can be up to 50 times more efficient than single CTCs in mediating viable metastasis. Here, combining computational ranking and functional determination, we identify the transmembrane protein Plexin-B2 (
Emma Schuster   +31 more
doaj   +1 more source

Circulating tumor plasma cells quantification in newly diagnosed transplant ineligible real world multiple myeloma patients: Comparison of single‐platform flow cytometry versus next generation flow

open access: yesCytometry Part B: Clinical Cytometry, EarlyView.
Abstract Circulating tumor plasma cells (CTCs) at diagnosis are independent prognostic markers in newly diagnosed multiple myeloma (NDMM). Flow cytometry (FC) enables sensitive and cost‐effective CTC quantification, but prognostic cut‐offs vary across studies.
Elona Saraci   +30 more
wiley   +1 more source

The utility of folate receptor-positive circulating tumor cell in cancer diagnosis in the elderly population

open access: yes, 2019
Na Li,1 Dingrong Zhong,2 Huang Chen,2 Tiequn Huang,1 Pihua Hou,1 Yinan Zhang,3 Fangling Chen,3 Xiaoping Wang,1 Hongchun Zhang11Department of Medical Health Care; 2Department of Pathology, China-Japan Friendship Hospital, Beijing 100029, People’s ...
Huang T   +8 more
core  

Epithelial‐to‐mesenchymal transition (EMT) to sarcoma in recurrent lung adenosquamous carcinoma following adjuvant chemotherapy

open access: yesThoracic Cancer, 2019
Adjuvant chemotherapy has long been indicated to extend survival in completely resected stage IB to IIIA non‐small cell lung cancer (NSCLC). However, there is accumulating evidence that chemotherapy or chemoradiotherapy can induce epithelial‐to ...
Mau Ern Poh   +7 more
doaj   +1 more source

Quantification of Rare Cancer Cells in Patients With Gastrointestinal Cancer by Nanostructured Substrate

open access: yesTranslational Oncology, 2014
Detecting the cancer cells in the peripheral blood, i.e. circulating tumor cell (CTC), have been considered as the “liquid biopsy” and become a particular area of focus.
Boran Cheng   +7 more
doaj   +1 more source

Is Ductal Carcinoma In Situ a Precursor or Low‐Risk Variant of Invasive Breast Cancer? A Population Perspective

open access: yesInternational Journal of Cancer, EarlyView.
ABSTRACT Ductal carcinoma in situ (DCIS) is usually detected with mammography screening and assumed to be a precursor of invasive ductal cancer (IDC) of the breast. Yet, despite an approximately 10‐fold increase in the rate of DCIS detection and treatment within 20 years following implementation of mammography screening in the United States, IDC ...
Ismail Jatoi   +4 more
wiley   +1 more source

Ovarian Cancer: Epidemiology, Disease Mechanisms, New Diagnosis and Treatment Strategies, and Research Directions

open access: yesiNew Medicine, EarlyView.
ABSTRACT Ovarian cancer (OC) continues to be the deadliest gynecological malignancy and a significant cause of cancer‐related mortality among women worldwide. Standard treatment strategies typically entail platinum‐based chemotherapy in conjunction with cytoreductive surgery.
Zunera Khalid   +4 more
wiley   +1 more source

Size-Based Enrichment Technologies for CTC Detection and Characterization

open access: yes, 2012
The degree of metastatic outspread in malignant disease is one of the leading factors in determining the appropriate course treatment. Circulating tumor cells (CTCs) represent the population of cells that have acquired the means to gain access to the ...
Datar, Ram   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy